1. Inicio
  2. Proyectos y Estudios
  3. POST-AUTHORISATION SAFETY STUDY (PASS): OBSERVATIONAL COHORT STUDY OF PAH PATIENTS NEWLY TREATED WITH EITHER UPTRAVI® (SELEXIPAG) OR ANY OTHER PAH-SPECIFIC THERAPY, IN CLINICAL PRACTICE. EXPOSURE. (EUROPEAN OBSERVATIONAL STUDY OF UPTRAVI IN REAL-LIFE).

POST-AUTHORISATION SAFETY STUDY (PASS): OBSERVATIONAL COHORT STUDY OF PAH PATIENTS NEWLY TREATED WITH EITHER UPTRAVI® (SELEXIPAG) OR ANY OTHER PAH-SPECIFIC THERAPY, IN CLINICAL PRACTICE. EXPOSURE. (EUROPEAN OBSERVATIONAL STUDY OF UPTRAVI IN REAL-LIFE).

Datos básicos

ESTUDIO OBSERVACIONAL INTERNACIONAL ACT-UPT-2017-01 HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE Año de incio: 2018

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

ACTELION PHARMACEUTICALS
ACTELION PHARMACEUTICALS LTD

Cita

Compartir